IBDEI047 ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,4286,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4286,1,4,0)
 ;;=3D4^284.9
 ;;^UTILITY(U,$J,358.3,4286,1,5,0)
 ;;=3D5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,4286,2)
 ;;=3D^7020
 ;;^UTILITY(U,$J,358.3,4287,0)
 ;;=3D282.61^^42^336^76
 ;;^UTILITY(U,$J,358.3,4287,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4287,1,4,0)
 ;;=3D4^282.61
 ;;^UTILITY(U,$J,358.3,4287,1,5,0)
 ;;=3D5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,4287,2)
 ;;=3D^267981
 ;;^UTILITY(U,$J,358.3,4288,0)
 ;;=3D282.7^^42^336^75
 ;;^UTILITY(U,$J,358.3,4288,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4288,1,4,0)
 ;;=3D4^282.7
 ;;^UTILITY(U,$J,358.3,4288,1,5,0)
 ;;=3D5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,4288,2)
 ;;=3D^87629
 ;;^UTILITY(U,$J,358.3,4289,0)
 ;;=3D283.9^^42^336^78
 ;;^UTILITY(U,$J,358.3,4289,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4289,1,4,0)
 ;;=3D4^283.9
 ;;^UTILITY(U,$J,358.3,4289,1,5,0)
 ;;=3D5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,4289,2)
 ;;=3D^7071
 ;;^UTILITY(U,$J,358.3,4290,0)
 ;;=3D283.0^^42^336^79
 ;;^UTILITY(U,$J,358.3,4290,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4290,1,4,0)
 ;;=3D4^283.0
 ;;^UTILITY(U,$J,358.3,4290,1,5,0)
 ;;=3D5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,4290,2)
 ;;=3D^7079
 ;;^UTILITY(U,$J,358.3,4291,0)
 ;;=3D282.9^^42^336^77
 ;;^UTILITY(U,$J,358.3,4291,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4291,1,4,0)
 ;;=3D4^282.9
 ;;^UTILITY(U,$J,358.3,4291,1,5,0)
 ;;=3D5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,4291,2)
 ;;=3D^56578
 ;;^UTILITY(U,$J,358.3,4292,0)
 ;;=3D283.19^^42^336^80
 ;;^UTILITY(U,$J,358.3,4292,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4292,1,4,0)
 ;;=3D4^283.19
 ;;^UTILITY(U,$J,358.3,4292,1,5,0)
 ;;=3D5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,4292,2)
 ;;=3D^293664
 ;;^UTILITY(U,$J,358.3,4293,0)
 ;;=3D280.9^^42^336^83
 ;;^UTILITY(U,$J,358.3,4293,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4293,1,4,0)
 ;;=3D4^280.9
 ;;^UTILITY(U,$J,358.3,4293,1,5,0)
 ;;=3D5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,4293,2)
 ;;=3D^276946
 ;;^UTILITY(U,$J,358.3,4294,0)
 ;;=3D285.1^^42^336^81
 ;;^UTILITY(U,$J,358.3,4294,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4294,1,4,0)
 ;;=3D4^285.1
 ;;^UTILITY(U,$J,358.3,4294,1,5,0)
 ;;=3D5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,4294,2)
 ;;=3D^267986
 ;;^UTILITY(U,$J,358.3,4295,0)
 ;;=3D280.0^^42^336^82
 ;;^UTILITY(U,$J,358.3,4295,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4295,1,4,0)
 ;;=3D4^280.0
 ;;^UTILITY(U,$J,358.3,4295,1,5,0)
 ;;=3D5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,4295,2)
 ;;=3D^267971
 ;;^UTILITY(U,$J,358.3,4296,0)
 ;;=3D281.9^^42^336^85
 ;;^UTILITY(U,$J,358.3,4296,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4296,1,4,0)
 ;;=3D4^281.9
 ;;^UTILITY(U,$J,358.3,4296,1,5,0)
 ;;=3D5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,4296,2)
 ;;=3D^123801
 ;;^UTILITY(U,$J,358.3,4297,0)
 ;;=3D281.0^^42^336^89
 ;;^UTILITY(U,$J,358.3,4297,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4297,1,4,0)
 ;;=3D4^281.0
 ;;^UTILITY(U,$J,358.3,4297,1,5,0)
 ;;=3D5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,4297,2)
 ;;=3D^7161
 ;;^UTILITY(U,$J,358.3,4298,0)
 ;;=3D282.60^^42^336^86
 ;;^UTILITY(U,$J,358.3,4298,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4298,1,4,0)
 ;;=3D4^282.60
 ;;^UTILITY(U,$J,358.3,4298,1,5,0)
 ;;=3D5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,4298,2)
 ;;=3D^7188
 ;;^UTILITY(U,$J,358.3,4299,0)
 ;;=3D282.62^^42^336^87
 ;;^UTILITY(U,$J,358.3,4299,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4299,1,4,0)
 ;;=3D4^282.62
 ;;^UTILITY(U,$J,358.3,4299,1,5,0)
 ;;=3D5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,4299,2)
 ;;=3D^267982
 ;;^UTILITY(U,$J,358.3,4300,0)
 ;;=3D281.1^^42^336^90
 ;;^UTILITY(U,$J,358.3,4300,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4300,1,4,0)
 ;;=3D4^281.1
 ;;^UTILITY(U,$J,358.3,4300,1,5,0)
 ;;=3D5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,4300,2)
 ;;=3D^267974
 ;;^UTILITY(U,$J,358.3,4301,0)
 ;;=3D286.7^^42^336^92
 ;;^UTILITY(U,$J,358.3,4301,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4301,1,4,0)
 ;;=3D4^286.7
 ;;^UTILITY(U,$J,358.3,4301,1,5,0)
 ;;=3D5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,4301,2)
 ;;=3D^2235
 ;;^UTILITY(U,$J,358.3,4302,0)
 ;;=3D287.4^^42^336^93
 ;;^UTILITY(U,$J,358.3,4302,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4302,1,4,0)
 ;;=3D4^287.4
 ;;^UTILITY(U,$J,358.3,4302,1,5,0)
 ;;=3D5^Thrombocytopenia, Drug Induced
 ;;^UTILITY(U,$J,358.3,4302,2)
 ;;=3D^267991
 ;;^UTILITY(U,$J,358.3,4303,0)
 ;;=3D289.9^^42^336^95
 ;;^UTILITY(U,$J,358.3,4303,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4303,1,4,0)
 ;;=3D4^289.9
 ;;^UTILITY(U,$J,358.3,4303,1,5,0)
 ;;=3D5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,4303,2)
 ;;=3D^55344
 ;;^UTILITY(U,$J,358.3,4304,0)
 ;;=3D451.9^^42^336^96
 ;;^UTILITY(U,$J,358.3,4304,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4304,1,4,0)
 ;;=3D4^451.9
 ;;^UTILITY(U,$J,358.3,4304,1,5,0)
 ;;=3D5^Thrombophlebitis=20
 ;;^UTILITY(U,$J,358.3,4304,2)
 ;;=3D^93357
 ;;^UTILITY(U,$J,358.3,4305,0)
 ;;=3D446.6^^42^336^97
 ;;^UTILITY(U,$J,358.3,4305,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4305,1,4,0)
 ;;=3D4^446.6
 ;;^UTILITY(U,$J,358.3,4305,1,5,0)
 ;;=3D5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,4305,2)
 ;;=3D^119061
 ;;^UTILITY(U,$J,358.3,4306,0)
 ;;=3D286.4^^42^336^98
 ;;^UTILITY(U,$J,358.3,4306,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4306,1,4,0)
 ;;=3D4^286.4
 ;;^UTILITY(U,$J,358.3,4306,1,5,0)
 ;;=3D5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,4306,2)
 ;;=3D^127267
 ;;^UTILITY(U,$J,358.3,4307,0)
 ;;=3D204.00^^42^336^101
 ;;^UTILITY(U,$J,358.3,4307,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4307,1,4,0)
 ;;=3D4^204.00
 ;;^UTILITY(U,$J,358.3,4307,1,5,0)
 ;;=3D5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,4307,2)
 ;;=3D^267521
 ;;^UTILITY(U,$J,358.3,4308,0)
 ;;=3D204.01^^42^336^100
 ;;^UTILITY(U,$J,358.3,4308,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4308,1,4,0)
 ;;=3D4^204.01
 ;;^UTILITY(U,$J,358.3,4308,1,5,0)
 ;;=3D5^All, In Remission
 ;;^UTILITY(U,$J,358.3,4308,2)
 ;;=3D^267522
 ;;^UTILITY(U,$J,358.3,4309,0)
 ;;=3D204.10^^42^336^103
 ;;^UTILITY(U,$J,358.3,4309,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4309,1,4,0)
 ;;=3D4^204.10
 ;;^UTILITY(U,$J,358.3,4309,1,5,0)
 ;;=3D5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,4309,2)
 ;;=3D^267523
 ;;^UTILITY(U,$J,358.3,4310,0)
 ;;=3D204.11^^42^336^102
 ;;^UTILITY(U,$J,358.3,4310,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4310,1,4,0)
 ;;=3D4^204.11
 ;;^UTILITY(U,$J,358.3,4310,1,5,0)
 ;;=3D5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,4310,2)
 ;;=3D^267524
 ;;^UTILITY(U,$J,358.3,4311,0)
 ;;=3D202.41^^42^336^104
 ;;^UTILITY(U,$J,358.3,4311,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4311,1,4,0)
 ;;=3D4^202.41
 ;;^UTILITY(U,$J,358.3,4311,1,5,0)
 ;;=3D5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,4311,2)
 ;;=3D^267472
 ;;^UTILITY(U,$J,358.3,4312,0)
 ;;=3D201.90^^42^336^105
 ;;^UTILITY(U,$J,358.3,4312,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4312,1,4,0)
 ;;=3D4^201.90
 ;;^UTILITY(U,$J,358.3,4312,1,5,0)
 ;;=3D5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,4312,2)
 ;;=3D^267430
 ;;^UTILITY(U,$J,358.3,4313,0)
 ;;=3D785.6^^42^336^106
 ;;^UTILITY(U,$J,358.3,4313,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4313,1,4,0)
 ;;=3D4^785.6
 ;;^UTILITY(U,$J,358.3,4313,1,5,0)
 ;;=3D5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,4313,2)
 ;;=3D^72368
 ;;^UTILITY(U,$J,358.3,4314,0)
 ;;=3D200.20^^42^336^107
 ;;^UTILITY(U,$J,358.3,4314,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4314,1,4,0)
 ;;=3D4^200.20
 ;;^UTILITY(U,$J,358.3,4314,1,5,0)
 ;;=3D5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,4314,2)
 ;;=3D^17529
 ;;^UTILITY(U,$J,358.3,4315,0)
 ;;=3D202.00^^42^336^109
 ;;^UTILITY(U,$J,358.3,4315,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4315,1,4,0)
 ;;=3D4^202.00
 ;;^UTILITY(U,$J,358.3,4315,1,5,0)
 ;;=3D5^Lymphoma, Low-Grade, Unspec Site
